Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma
Vikrant Rai, Joe Abdo, Abdullah Alsuwaidan, et al.
Molecular and Cellular Biochemistry (2017) Vol. 437, Iss. 1-2, pp. 13-36
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

The immunology of hepatocellular carcinoma
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 865
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of tumor response in hepatocellular carcinoma after DEB-TACE
Isabel Schobert, Lynn Jeanette Savic, Julius Chapiro, et al.
European Radiology (2020) Vol. 30, Iss. 10, pp. 5663-5673
Open Access | Times Cited: 98
The progress of immune checkpoint therapy in primary liver cancer
Yi-Min Zheng, Siwei Wang, Jia‐Bin Cai, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2021) Vol. 1876, Iss. 2, pp. 188638-188638
Closed Access | Times Cited: 66
Iron metabolism gene expression and prognostic features of hepatocellular carcinoma
Ying Shen, Xin Li, Bin Zhao, et al.
Journal of Cellular Biochemistry (2018) Vol. 119, Iss. 11, pp. 9178-9204
Closed Access | Times Cited: 66
Myeloid signature reveals immune contexture and predicts the prognosis of hepatocellular carcinoma
Chong Wu, Jie Lin, Yulan Weng, et al.
Journal of Clinical Investigation (2020) Vol. 130, Iss. 9, pp. 4679-4693
Open Access | Times Cited: 60
The role of the innate immune system in the development and treatment of hepatocellular carcinoma
Christoph Roderburg, Alexander Wree, Münevver Demir, et al.
Hepatic Oncology (2020) Vol. 7, Iss. 1
Open Access | Times Cited: 59
Combination of Tertiary Lymphoid Structure and Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients With Hepatocellular Carcinoma
Shaodi Wen, Yuzhong Chen, Chupeng Hu, et al.
Frontiers in Immunology (2022) Vol. 12
Open Access | Times Cited: 34
Role of modern radiotherapy in managing patients with hepatocellular carcinoma
Liang‐Cheng Chen, Hon‐Yi Lin, Shih‐Kai Hung, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 20, pp. 2434-2457
Open Access | Times Cited: 30
Navigating liver cancer: Precision targeting for enhanced treatment outcomes
Ankit Jain, Ashwini Kumar Mishra, Pooja Hurkat, et al.
Drug Delivery and Translational Research (2025)
Closed Access
The role of immune regulation in HBV infection and hepatocellular carcinogenesis
Hailong Zheng, Bingchen Xu, Yiyu Fan, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
A prognosis and impact factor analysis of DC-CIK cell therapy for patients with hepatocellular carcinoma undergoing postoperative TACE
Jian Zhang, Huizhong Li, Dazhi Gao, et al.
Cancer Biology & Therapy (2018) Vol. 19, Iss. 6, pp. 475-483
Open Access | Times Cited: 32
Correlation between inflammatory cytokines and the likelihood of developing multiple types of digestive system cancers: A Mendelian randomization study
S. Chen, Bin Zhang, Song Wang, et al.
Cytokine (2024) Vol. 183, pp. 156735-156735
Open Access | Times Cited: 3
MicroRNA-26b-5p enhances T cell responses by targeting PIM-2 in hepatocellular carcinoma
W. Han, Ning Li, Jun Liu, et al.
Cellular Signalling (2018) Vol. 59, pp. 182-190
Closed Access | Times Cited: 24
Novel antigens for targeted radioimmunotherapy in hepatocellular carcinoma
Mahsa Pourhamzeh, Samieh Asadian, Hamed Mirzaei, et al.
Molecular and Cellular Biochemistry (2022) Vol. 478, Iss. 1, pp. 23-37
Closed Access | Times Cited: 13
Liver, Tumor and Viral Hepatitis: Key Players in the Complex Balance Between Tolerance and Immune Activation
Matti Sällberg, Anna Pasetto
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 17
MicroRNAs: Regulators of immunological reactions in hepatocellular carcinoma
Meenakshi Gupta, Jamal Akhtar, Maryam Sarwat
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 127-133
Closed Access | Times Cited: 16
Stereotactic Body Radiotherapy: Does It Have a Role in Management of Hepatocellular Carcinoma?
Seo Hee Choi, Jinsil Seong
Yonsei Medical Journal (2018) Vol. 59, Iss. 8, pp. 912-912
Open Access | Times Cited: 18
Immunological basis for treatment of graft versus host disease after liver transplant
Vikrant Rai, Nicholas Dietz, Devendra K. Agrawal
Expert Review of Clinical Immunology (2016) Vol. 12, Iss. 5, pp. 583-593
Open Access | Times Cited: 15
Targets of immunotherapy for hepatocellular carcinoma: An update
Vikrant Rai, Sandeep Mukherjee
World Journal of Hepatology (2022) Vol. 14, Iss. 1, pp. 140-157
Open Access | Times Cited: 9
Prognostic value of inflammation‑based indexes for intrahepatic cholangiocarcinoma following curative resection
Yunhua Wu, Fenggang Ren, Yichao Chai, et al.
Oncology Letters (2018)
Open Access | Times Cited: 16
Innate immune cells and their interaction with T cells in hepatocellular carcinoma (Review)
Guoqing Hong, Dong Cai, Jianping Gong, et al.
Oncology Letters (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Intravital imaging of interactions between iNKT and kupffer cells to clear free lipids during steatohepatitis
Haitao Wang, Longjun Li, Yinling Li, et al.
Theranostics (2020) Vol. 11, Iss. 5, pp. 2149-2169
Open Access | Times Cited: 13
Expression Differentiation Is Not Helpful in Identifying Prognostic Genes Based on TCGA Datasets
Ning An, Zhuang Yu, Xue Yang
Molecular Therapy — Nucleic Acids (2018) Vol. 11, pp. 292-299
Open Access | Times Cited: 14
Etiology-Specific Analysis of Hepatocellular Carcinoma Transcriptome Reveals Genetic Dysregulation in Pathways Implicated in Immunotherapy Efficacy
Wei Tse Li, Angela E. Zou, Christine O. Honda, et al.
Cancers (2019) Vol. 11, Iss. 9, pp. 1273-1273
Open Access | Times Cited: 11
<p>Intratumoral IL-12 Gene Therapy Inhibits Tumor Growth In A HCC-Hu-PBL-NOD/SCID Murine Model</p>
Zhifeng Zhou, Feng Peng, Jieyu Li, et al.
OncoTargets and Therapy (2019) Vol. Volume 12, pp. 7773-7784
Open Access | Times Cited: 11
Page 1 - Next Page

Scroll to top